Patent holdings for IPC class C07D 281/10

Total number of patents in this class: 147

10-year publication summary

6
2
11
11
17
22
12
10
10
1
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Albireo AB
173
32
Elobix AB
17
15
RyCarma Therapeutics, Inc.
27
10
Glaxosmithkline Intellectual Property (no.2) Limited
301
8
Glaxosmithkline Intellectual Property Development Limited
774
7
Armgo Pharma, Inc.
12
7
Shire Human Genetic Therapies, Inc.
190
7
Assembly Biosciences, Inc.
97
3
VALO Health, Inc.
186
3
Novartis AG
10341
2
Glaxosmithkline LLC
529
2
Merck Sharp & Dohme Corp.
2184
2
Assia Chemical Industries Ltd.
223
2
KYORIN Pharmaceutical Co., Ltd.
162
2
Les Laboratoires Servier
500
2
Shanghai Institute of Pharmaceutical Industry
127
2
HK Inno.n Corporation
118
2
Shanghai Zhongze Therapeutics, Co. Ltd.
5
2
Hainan Jin Rui Pharmaceutical Co., Ltd.
8
2
F. Hoffmann-La Roche AG
7841
1
Other owners 34